Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Avanos Medical Inc (NYSE: AVNS) closed at $15.40 down -0.39% from its previous closing price of $15.46. In other words, the price has decreased by -$0.39 from its previous closing price. On the day, 1.23 million shares were traded. AVNS stock price reached its highest trading level at $15.54 during the session, while it also had its lowest trading level at $15.22.
Ratios:
For a deeper understanding of Avanos Medical Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.34. For the most recent quarter (mrq), Quick Ratio is recorded 1.46 and its Current Ratio is at 2.22. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.15.
On May 22, 2023, CL King started tracking the stock assigning a Buy rating and target price of $31.
Stephens Downgraded its Overweight to Equal-Weight on August 04, 2021, whereas the target price for the stock was revised from $60 to $45.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 14 ’24 when Greiner Michael sold 8,000 shares for $19.12 per share. The transaction valued at 152,980 led to the insider holds 151,495 shares of the business.
Shimer Julie Ann bought 500 shares of AVNS for $9,925 on Mar 11 ’24. The Director now owns 50,090 shares after completing the transaction at $19.85 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVNS now has a Market Capitalization of 707737792 and an Enterprise Value of 821600000. As of this moment, Avanos’s Price-to-Earnings (P/E) ratio for their current fiscal year is 45.66, and their Forward P/E ratio for the next fiscal year is 9.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.04 while its Price-to-Book (P/B) ratio in mrq is 0.58. Its current Enterprise Value per Revenue stands at 1.206 whereas that against EBITDA is 8.039.
Stock Price History:
Over the past 52 weeks, AVNS has reached a high of $25.36, while it has fallen to a 52-week low of $15.37. The 50-Day Moving Average of the stock is -15.54%, while the 200-Day Moving Average is calculated to be -25.12%.
Shares Statistics:
For the past three months, AVNS has traded an average of 308.78K shares per day and 378090 over the past ten days. A total of 45.95M shares are outstanding, with a floating share count of 44.88M. Insiders hold about 2.34% of the company’s shares, while institutions hold 94.17% stake in the company. Shares short for AVNS as of 1734048000 were 727689 with a Short Ratio of 2.36, compared to 1731628800 on 552329. Therefore, it implies a Short% of Shares Outstanding of 727689 and a Short% of Float of 2.26.
